Skip to main content
Puneeth Iyengar, MD, Radiation Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

PuneethIyengarMD

Radiation Oncology New York, NY

Attending and Director of the Metastatic Program, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York

Dr. Iyengar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Iyengar's full profile

Already have an account?

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2006 - 2010
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonInternship, Internal Medicine, 2005 - 2006
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2005
  • Massachusetts Institute of Technology
    Massachusetts Institute of TechnologyB.S., 1993 - 1997

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2023 - Present
  • NY State Medical License
    NY State Medical License 2023 - 2025
  • NJ State Medical License
    NJ State Medical License 2023 - 2025
  • TX State Medical License
    TX State Medical License 2010 - 2023
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Educator of the Year Teaching Award ARRO (Association of Residents in Radiation Oncology), 2016
  • Translational Research Award Sidney Kimmel Cancer Research Foundation, 2013
  • President's Research Council Award Winner UT Southwestern Medical Center, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial  
    Iyengar P, Wardak Z, Gerber DE, Tumati V, Ahn C, Hughes RS, Dowell JE, Cheedella N, Nedzi L, Westover KD, Pulipparacharuvil S, Choy H, Timmerman RD, JAMA Oncol, 1/11/2018
  • Shell feature: a new radiomics descriptor for predicting distant failure after radiotherapy in non-small cell lung cancer and cervix cancer  
    Hao H, Zhou Z, Li S, Maquilan G, Folkert MR, Iyengar P, Westover KD, Albuquerque K, Liu F, Choy H, Timmerman R, Yang L, Wang J, Phys Med Biol, 1/2/2018
  • Adipocyte Xbp1s overexpression drives uridine production and reduces obesity  
    Deng Y, Wang ZV, Gordillo R, Zhu Y, Ali A, Zhang C, Wang X, Shao M, Zhang Z, Iyengar P, Gupta RK, Horton JD, Hill JA, Scherer PE, Mol Metab, 1/2/2018
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • From Surgery to Radiosurgery: New Horizons 
    Spezia, Italy - 1/1/2017
  • New Developments in Cancer Cachexia 
    Bangalore - 1/1/2012
  • Respiratory Tumors-Therapy and Biology 
    Dallas - 1/1/2011
  • Join now to see all

Press Mentions

  • Patient-Centered Approach Recommended for Oligometastatic NSCLC
    Patient-Centered Approach Recommended for Oligometastatic NSCLCMay 3rd, 2023
  • First Guideline for Treating Oligometastatic NSCLC
    First Guideline for Treating Oligometastatic NSCLCApril 28th, 2023
  • ASTRO/ESTRO's Clinical Guideline Offers Recommendations on the Use of Local Therapy for Oligometastatic NSCLC
    ASTRO/ESTRO's Clinical Guideline Offers Recommendations on the Use of Local Therapy for Oligometastatic NSCLCApril 25th, 2023
  • Join now to see all

Hospital Affiliations